Why is Intuitive Surgical proposing to merge with Computer Motion?

Management argues the combination creates a strategic fit across technologies, intellectual property, and focus areas, and it would end costly patent litigation between the companies. The company also expects roughly $18 million in annual pre-tax cost savings, largely from headcount reductions, beginning in late 2003, though it notes these savings are not guaranteed.

How much dilution will shareholders face from the merger?

The filing estimates about 15.6 million new shares will be issued to Computer Motion stockholders plus roughly 4.8 million shares reserved for assumed options and warrants. Pre-merger holders would own about 70% of the combined company and former Computer Motion holders about 30%, subject to change based on closing conditions and share prices.

What is the company's near-term liquidity outlook?

Cash, equivalents, and short-term investments were $50.8 million at December 31, 2002. Management expects current resources plus product revenue to be sufficient through 2003. Intuitive also agreed to provide up to $7.3 million in bridge financing to Computer Motion, and the combined cash of both companies is projected to be below $35 million at closing, so future equity or debt raises are possible.

What are the biggest legal risks to the business?

The most significant risks are the Brookhill-Wilk patent suit, where the Federal Circuit reversed a summary judgment of noninfringement in April 2003, and Computer Motion's patent suits against the da Vinci system. If Intuitive loses, it could face treble damages, injunctions, or the need to license technology on unfavorable terms. Litigation is stayed pending the merger but could resume if it fails.

What drives revenue growth and what limits it?

Growth comes from system placements, rising average selling prices, and a growing installed base generating recurring instrument and service revenue. Constraints include long, variable capital sales cycles requiring senior management approval, limited surgeon training capacity, reliance on FDA clearances for specific procedures, uncertain third-party reimbursement, and dependence on sole-source component suppliers.

ISRG 10-K Filed May 30, 2003

01—Abstract

Summary

Summary of the 10-K/A filed May 30, 2003. Cited figures are marked; the original filing is the authoritative source.

Intuitive Surgical's FY2002 10-K (filed May 30, 2003) shows a company still in an early commercialization phase for its da Vinci Surgical System.

Revenue rose 39% to $72.0 million^a in 2002, driven by 60 system sales (versus 49 in 2001) at an average selling price of $948,000 and recurring instrument, accessory, and service revenue that grew 116% to $15.1 million. Gross margin improved to 52% from 45%, yet the company still posted a net loss of $18.4 million, and cash, equivalents and short-term investments fell to $50.8 million from $66.7 million. Management states that current resources are sufficient through 2003, but operating losses and cash burn remain a concern.

The dominant strategic event is the pending merger with rival Computer Motion, announced March 7, 2003. Intuitive expects to issue about 15.6 million shares (roughly 30% of the combined company to Computer Motion holders, per the filing's estimate) and projects roughly $18 million^b in annual pre-tax cost savings beginning late 2003. The deal would also end a sprawling set of patent suits between the two companies, though the litigation is currently stayed through August 31, 2003 and could resume if the merger fails.

Investors should weigh the synergy and litigation-resolution upside against dilution, integration risk, and the uncertain outcome of pending patent matters, including the Brookhill-Wilk case, which the Federal Circuit reversed in April 2003. Longer term, the company's thesis depends on surgeon adoption of its platform for complex procedures, expanding FDA clearances, and growing the recurring revenue base from instruments and service. Heavy reliance on high-priced capital systems, a small number of sales per quarter, sole-source components, and reimbursement uncertainty all remain material risks highlighted in the filing.

02—Key points

Key Highlights

Revenue grew 39% to $72.0 million in 2002, with 60 da Vinci systems sold versus 49 in 2001, and 149 cumulative systems placed by year-end 2002.
Gross margin expanded to 52% in 2002 from 45% in 2001, reflecting higher average selling prices ($948,000) and improved manufacturing efficiency and service contribution.
Recurring instrument, accessory, and service revenue reached $15.1 million (21% of sales), up 116% year over year.
Net loss narrowed slightly to $18.4 million from $16.7 million in 2001 (net loss widened, actually, from $16.7M to $18.4M); cash and short-term investments declined to $50.8 million from $66.7 million.
Pending merger with Computer Motion (announced March 7, 2003) would issue roughly 15.6 million shares, leaving current holders with about 70% ownership, and targets about $18 million in annual pre-tax cost savings starting late 2003.
Extensive patent litigation with Computer Motion and Brookhill-Wilk is stayed through August 31, 2003; a favorable Federal Circuit ruling against Intuitive in the Wilk appeal (April 2003) adds legal uncertainty.
Management believes existing cash plus product revenue will fund operations at least through 2003, but the combined company may need additional financing thereafter.

03—Questions

Frequently Asked Questions

Why is Intuitive Surgical proposing to merge with Computer Motion?
Management argues the combination creates a strategic fit across technologies, intellectual property, and focus areas, and it would end costly patent litigation between the companies. The company also expects roughly $18 million in annual pre-tax cost savings, largely from headcount reductions, beginning in late 2003, though it notes these savings are not guaranteed.
How much dilution will shareholders face from the merger?
The filing estimates about 15.6 million new shares will be issued to Computer Motion stockholders plus roughly 4.8 million shares reserved for assumed options and warrants. Pre-merger holders would own about 70% of the combined company and former Computer Motion holders about 30%, subject to change based on closing conditions and share prices.
What is the company's near-term liquidity outlook?
Cash, equivalents, and short-term investments were $50.8 million at December 31, 2002. Management expects current resources plus product revenue to be sufficient through 2003. Intuitive also agreed to provide up to $7.3 million in bridge financing to Computer Motion, and the combined cash of both companies is projected to be below $35 million at closing, so future equity or debt raises are possible.
What are the biggest legal risks to the business?
The most significant risks are the Brookhill-Wilk patent suit, where the Federal Circuit reversed a summary judgment of noninfringement in April 2003, and Computer Motion's patent suits against the da Vinci system. If Intuitive loses, it could face treble damages, injunctions, or the need to license technology on unfavorable terms. Litigation is stayed pending the merger but could resume if it fails.
What drives revenue growth and what limits it?
Growth comes from system placements, rising average selling prices, and a growing installed base generating recurring instrument and service revenue. Constraints include long, variable capital sales cycles requiring senior management approval, limited surgeon training capacity, reliance on FDA clearances for specific procedures, uncertain third-party reimbursement, and dependence on sole-source component suppliers.

04—Continue

← View all 10-K filings